A new combination therapy
By Pfizer could lower the risk of prostate cancer's misery
Talazoparib and enzalutamide
Was tested in phase 3, and the results were grand
The risk of progression or death was reduced by thirty-seven

#prostatecancer #talazoparib #enzalutamide #combinationtherapy #limerick #poetry

http://www.medicalnewstoday.com/articles/prostate-cancer-new-combination-therapy-could-reduce-progression-risk

Two important papers on #talazoparib and #avelumab in #solidtumors. Take home messsage: BRCA is associated with most responses and no clear advantage of combo over monotherapy with a caveat of being careful about cross-trial comparisons

Two important papers on #talazoparib and #avelumab in #solidtumors. Take home messsage: BRCA is associated with most responses and no clear advantage of combo over monotherapy